NASDAQ:PSNL - Personalis Stock Price, Forecast & News

Personalis trades on the NASDAQ under the ticker symbol "PSNL."

Personalis (NASDAQ:PSNL) posted its earnings results on Wednesday, November, 13th. The company reported ($0.22) EPS for the quarter, beating analysts' consensus estimates of ($0.25) by $0.03. The business had revenue of $17.20 million for the quarter, compared to analysts' expectations of $15.77 million. Personalis's revenue for the quarter was up 47.0% on a year-over-year basis. View Personalis' Earnings History.

Personalis is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for Personalis.

Personalis updated its FY 2019 After-Hours earnings guidance on Monday, November, 25th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $$64.5-65 million, compared to the consensus revenue estimate of $$61.68 million.

5 brokers have issued 1-year price targets for Personalis' shares. Their forecasts range from $22.00 to $29.00. On average, they expect Personalis' stock price to reach $26.25 in the next twelve months. This suggests a possible upside of 117.8% from the stock's current price. View Analyst Price Targets for Personalis.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Personalis in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Personalis.

Press coverage about PSNL stock has trended somewhat negative on Thursday, according to InfoTrie. The research firm rates the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Personalis earned a coverage optimism score of -1.2 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Personalis.

Personalis saw a increase in short interest during the month of December. As of December 31st, there was short interest totalling 1,270,000 shares, an increase of 23.3% from the December 15th total of 1,030,000 shares. Based on an average daily trading volume, of 403,200 shares, the short-interest ratio is presently 3.1 days. Approximately 7.8% of the company's stock are short sold. View Personalis' Current Options Chain.

Some companies that are related to Personalis include RadNet (RDNT), CareDx (CDNA), Castle Biosciences (CSTL), Centogene (CNTG), Fulgent Genetics (FLGT), DermTech (DMTK), Enzo Biochem (ENZ), Celcuity (CELC), Psychemedics (PMD), PotNetwork (POTN), Miragen Therapeutics (MGEN), Biocept (BIOC), Avant Diagnostics (AVDX), OpGen (OPGN) and CBA Florida (CBAI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Personalis investors own include Alibaba Group (BABA), Verizon Communications (VZ), Cisco Systems (CSCO), Editas Medicine (EDIT), CVS Health (CVS), Home Depot (HD), Honeywell International (HON), Pfizer (PFE), Raytheon (RTN) and Thermo Fisher Scientific (TMO).

(PSNL) raised $100 million in an initial public offering (IPO) on Thursday, June 20th 2019. The company issued 6,700,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley, BofA Merrill Lynch and Cowen and Company served as the underwriters for the IPO and Oppenheimer was co-manager.

Personalis' lock-up period expired on Tuesday, December 17th. Personalis had issued 7,921,500 shares in its IPO on June 20th. The total size of the offering was $134,665,500 based on an initial share price of $17.00. Since the end of Personalis' lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company have been lifted.

Personalis' stock is owned by many different of institutional and retail investors. Top institutional shareholders include FNY Investment Advisers LLC (0.17%). View Institutional Ownership Trends for Personalis.

PSNL stock was purchased by a variety of institutional investors in the last quarter, including FNY Investment Advisers LLC. View Insider Buying and Selling for Personalis.

Shares of PSNL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of PSNL stock can currently be purchased for approximately $12.05.

Personalis has a market capitalization of $376.32 million. Personalis employs 147 workers across the globe.View Additional Information About Personalis.

The official website for Personalis is http://www.personalis.com/.

Personalis' mailing address is 1330 O`BRIEN DRIVE, MENLO PARK CA, 94025. The company can be reached via phone at 650-752-1300 or via email at [email protected]